Olena Barbash

4Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville, PA.

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Limited antitumor activity of combined BET and MEK inhibition in neuroblastoma”.

Limited antitumor activity of combined BET and MEK inhibition in neuroblastoma

Pediatric Blood & Cancer(2020)10.1002/pbc.28267

N/A

0.925DataRank · unranked

21 citations

Lori S. Hart, Alexander L. Shazad, Maria Gagliardi, Matthew Tsang, Jimmy Elias +11 more

SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer

Nature(2014)10.1038/nature13320

N/A

0.902DataRank · unranked

407 citations

Nicolas Reynoird, Purvesh Khatri, Alex W. Wilkinson, Shichong Liu, Olena Barbash +14 more

TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma

Nature Communications(2022)10.1038/s41467-022-33137-8

N/A

0.510DataRank · unranked

29 citations

Chiara M. Evans, Daniel Zakheim, Eren L. Chu, Alice Yunsi Refermat, Zahra Asgari +18 more

Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses

Cancer Immunology Research(2022)10.1158/2326-6066.cir-21-0614

N/A

0DataRank · unranked

32 citations

Leilei Shi, Shane W. O’Brien, Kimberly N. Smitheman, Yunfei Wang, Jiakai Hou +15 more